203 related articles for article (PubMed ID: 31300339)
21. Association of anticholinergic drug exposure with the risk of dementia among older adults in Japan: The LIFE Study.
Okita Y; Kitamura T; Komukai S; Zha L; Komatsu M; Narii N; Murata F; Megumi M; Gon Y; Kimura Y; Kiyohara K; Sobue T; Fukuda H
Int J Geriatr Psychiatry; 2023 Dec; 38(12):e6029. PubMed ID: 38041399
[TBL] [Abstract][Full Text] [Related]
22. Anticholinergic Drug Burden in Persons with Dementia Taking a Cholinesterase Inhibitor: The Effect of Multiple Physicians.
Reppas-Rindlisbacher CE; Fischer HD; Fung K; Gill SS; Seitz D; Tannenbaum C; Austin PC; Rochon PA
J Am Geriatr Soc; 2016 Mar; 64(3):492-500. PubMed ID: 27000323
[TBL] [Abstract][Full Text] [Related]
23. Risk of hospitalization associated with anticholinergic medication for patients with dementia.
Watanabe S; Fukatsu T; Kanemoto K
Psychogeriatrics; 2018 Jan; 18(1):57-63. PubMed ID: 29372598
[TBL] [Abstract][Full Text] [Related]
24. Assessing Risks of Polypharmacy Involving Medications With Anticholinergic Properties.
Hanlon P; Quinn TJ; Gallacher KI; Myint PK; Jani BD; Nicholl BI; Lowrie R; Soiza RL; Neal SR; Lee D; Mair FS
Ann Fam Med; 2020 Mar; 18(2):148-155. PubMed ID: 32152019
[TBL] [Abstract][Full Text] [Related]
25. Effect of anticholinergic burden on treatment modification, delirium and mortality in newly diagnosed dementia patients starting a cholinesterase inhibitor: A population-based study.
Ah YM; Suh Y; Jun K; Hwang S; Lee JY
Basic Clin Pharmacol Toxicol; 2019 Jun; 124(6):741-748. PubMed ID: 30511428
[TBL] [Abstract][Full Text] [Related]
26. Anticholinergic Burden and Risk of Stroke and Death in People with Different Types of Dementia.
Tan ECK; Eriksdotter M; Garcia-Ptacek S; Fastbom J; Johnell K
J Alzheimers Dis; 2018; 65(2):589-596. PubMed ID: 30056424
[TBL] [Abstract][Full Text] [Related]
27. Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis.
Pieper NT; Grossi CM; Chan WY; Loke YK; Savva GM; Haroulis C; Steel N; Fox C; Maidment ID; Arthur AJ; Myint PK; Smith TO; Robinson L; Matthews FE; Brayne C; Richardson K
Age Ageing; 2020 Oct; 49(6):939-947. PubMed ID: 32603415
[TBL] [Abstract][Full Text] [Related]
28. Cumulative anticholinergic exposure is associated with poor memory and executive function in older men.
Han L; Agostini JV; Allore HG
J Am Geriatr Soc; 2008 Dec; 56(12):2203-10. PubMed ID: 19093918
[TBL] [Abstract][Full Text] [Related]
29. Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study.
Gray SL; Dublin S; Yu O; Walker R; Anderson M; Hubbard RA; Crane PK; Larson EB
BMJ; 2016 Feb; 352():i90. PubMed ID: 26837813
[TBL] [Abstract][Full Text] [Related]
30. Benzodiazepine, psychotropic medication, and dementia: A population-based cohort study.
Shash D; Kurth T; Bertrand M; Dufouil C; Barberger-Gateau P; Berr C; Ritchie K; Dartigues JF; Bégaud B; Alpérovitch A; Tzourio C
Alzheimers Dement; 2016 May; 12(5):604-13. PubMed ID: 26602630
[TBL] [Abstract][Full Text] [Related]
31. Use of Medications with Anticholinergic Activity and Self-Reported Injurious Falls in Older Community-Dwelling Adults.
Richardson K; Bennett K; Maidment ID; Fox C; Smithard D; Kenny RA
J Am Geriatr Soc; 2015 Aug; 63(8):1561-9. PubMed ID: 26200894
[TBL] [Abstract][Full Text] [Related]
32. Anticholinergic burden before and after hospitalization in older adults with dementia: Increase due to antipsychotic medications.
Reinold J; Palese F; Romanese F; Logroscino G; Riedel O; Pisa FE
Int J Geriatr Psychiatry; 2019 Jun; 34(6):868-880. PubMed ID: 30761624
[TBL] [Abstract][Full Text] [Related]
33. CYP2C9 Genotypes Modify Benzodiazepine-Related Fall Risk: Original Results From Three Studies With Meta-Analysis.
Ham AC; Ziere G; Broer L; Swart KM; Enneman AW; van Dijk SC; van Wijngaarden JP; van der Zwaluw NL; Brouwer-Brolsma EM; Dhonukshe-Rutten RA; van Schoor NM; Zillikens MC; van Gelder T; de Vries OJ; Lips P; Deeg DJ; de Groot LC; Hofman A; Witkamp RF; Uitterlinden AG; Stricker BH; van der Velde N
J Am Med Dir Assoc; 2017 Jan; 18(1):88.e1-88.e15. PubMed ID: 27889507
[TBL] [Abstract][Full Text] [Related]
34. Benzodiazepine use and risk of dementia: prospective population based study.
Billioti de Gage S; Bégaud B; Bazin F; Verdoux H; Dartigues JF; Pérès K; Kurth T; Pariente A
BMJ; 2012 Sep; 345():e6231. PubMed ID: 23045258
[TBL] [Abstract][Full Text] [Related]
35. Anticholinergics Influence Transition from Normal Cognition to Mild Cognitive Impairment in Older Adults in Primary Care.
Campbell NL; Lane KA; Gao S; Boustani MA; Unverzagt F
Pharmacotherapy; 2018 May; 38(5):511-519. PubMed ID: 29600808
[TBL] [Abstract][Full Text] [Related]
36. Relation between anticholinergic burden and cognitive impairment: Results from the Monzino 80-plus population-based study.
Pasina L; Lucca U; Tettamanti M
Pharmacoepidemiol Drug Saf; 2020 Dec; 29(12):1696-1702. PubMed ID: 33098318
[TBL] [Abstract][Full Text] [Related]
37. Relation Between Delirium and Anticholinergic Drug Burden in a Cohort of Hospitalized Older Patients: An Observational Study.
Pasina L; Colzani L; Cortesi L; Tettamanti M; Zambon A; Nobili A; Mazzone A; Mazzola P; Annoni G; Bellelli G
Drugs Aging; 2019 Jan; 36(1):85-91. PubMed ID: 30484239
[TBL] [Abstract][Full Text] [Related]
38. Changes in the Use of Long-Term Medications Following Incident Dementia Diagnosis.
Anderson TS; Ayanian JZ; Curto VE; Politzer E; Souza J; Zaslavsky AM; Landon BE
JAMA Intern Med; 2023 Oct; 183(10):1098-1108. PubMed ID: 37603340
[TBL] [Abstract][Full Text] [Related]
39. Drug Burden Index and change in cognition over time in community-dwelling older men: the CHAMP study.
Jamsen KM; Gnjidic D; Hilmer SN; Ilomäki J; Le Couteur DG; Blyth FM; Handelsman DJ; Naganathan V; Waite LM; Cumming RG; Bell JS
Ann Med; 2017 Mar; 49(2):157-164. PubMed ID: 27763767
[TBL] [Abstract][Full Text] [Related]
40. Is Benzodiazepine Use Associated With the Risk of Dementia and Cognitive Impairment-Not Dementia in Older Persons? The Canadian Study of Health and Aging.
Nafti M; Sirois C; Kröger E; Carmichael PH; Laurin D
Ann Pharmacother; 2020 Mar; 54(3):219-225. PubMed ID: 31595772
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
